insights_auto
Outlook: 45.3% bullish·4.7% bearish
Go to analysischevron_right
LLY:NYSE
Eli Lilly And Co
1 443,50 US$
arrow_upward
+1,04%(+14,80) 1D
1 439,99 US$
arrow_downward
-0,24% (-3,51)bedtimeAfter hours
Closed: 13 ნოე, 16:01:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LLY...
Open
1 429,91 US$
High
1 449,64 US$
Low
1 419,77 US$
Mkt. cap
1,36 ტრლ.
Avg. vol.
2,77 მლნ.
Volume
2,08 მლნ.
Dividend
0,48%
Quarterly dividend
1,73 US$
Ex-dividend date
13 ნოე. 2026
P/E ratio
46,86
52-wk high
1 460,00 US$
52-wk low
850,51 US$
EPS
30,81 US$
Beta
0,40
Shares outstanding
940,74 მლნ.
No. of employees
50 ათ.
Open
1 429,91 US$
High
1 449,64 US$
Low
1 419,77 US$
Mkt. cap
1,36 ტრლ.
Avg. vol.
2,77 მლნ.
Volume
2,08 მლნ.
Dividend
0,48%
Quarterly dividend
1,73 US$
Ex-dividend date
13 ნოე. 2026
P/E ratio
46,86
52-wk high
1 460,00 US$
52-wk low
850,51 US$
EPS
30,81 US$
Beta
0,40
Shares outstanding
940,74 მლნ.
No. of employees
50 ათ.
News stories
From web sources and news partners
Trefis
·
4 საათის წინ
What Is The Market Seeing In Eli Lilly Stock?
Zacks
·
12 საათის წინ
HIMS Partners With Lilly to Offer FDA-Approved Weight-Loss Drugs
Zacks
·
12 საათის წინ
NKTR Q3 Earnings Beat Estimates, 2026 Revenue View Cut, Stock Down
Pharmaceutical Executive
·
13 საათის წინ
Eli Lilly Breaks Ground on $3.5 billion Pennsylvania Manufacturing Site
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 36 countries. Its products are marketed in approximately 90 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
About Eli Lilly And Co
CEOდეივიდ ეი რიკსი
Employees50 ათ.
Founded1876
Headquartersინდიანაპოლისი, ინდიანა, ამერიკის შეერთებული შტატები
SectorHealth Care
IndustryPharmaceutical industry
Websitelilly.com